149 related articles for article (PubMed ID: 28931663)
1. Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.
Wortley MA; Adcock JJ; Dubuis ED; Maher SA; Bonvini SJ; Delescluse I; Kinloch R; McMurray G; Perros-Huguet C; Papakosta M; Birrell MA; Belvisi MG
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931663
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of guinea-pig and human sensory nerve activity and the cough reflex in guinea-pigs by cannabinoid (CB2) receptor activation.
Patel HJ; Birrell MA; Crispino N; Hele DJ; Venkatesan P; Barnes PJ; Yacoub MH; Belvisi MG
Br J Pharmacol; 2003 Sep; 140(2):261-8. PubMed ID: 12970104
[TBL] [Abstract][Full Text] [Related]
3. Theophylline inhibits the cough reflex through a novel mechanism of action.
Dubuis E; Wortley MA; Grace MS; Maher SA; Adcock JJ; Birrell MA; Belvisi MG
J Allergy Clin Immunol; 2014 Jun; 133(6):1588-98. PubMed ID: 24406072
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential channels mediate the tussive response to prostaglandin E2 and bradykinin.
Grace M; Birrell MA; Dubuis E; Maher SA; Belvisi MG
Thorax; 2012 Oct; 67(10):891-900. PubMed ID: 22693178
[TBL] [Abstract][Full Text] [Related]
5. Beta(2)-agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway.
Freund-Michel VC; Birrell MA; Giembycz MA; Hele DJ; Haj-Yahia S; Belvisi MG
Eur Respir J; 2010 Mar; 35(3):647-54. PubMed ID: 19679606
[TBL] [Abstract][Full Text] [Related]
6. Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.
Guindon J; Lai Y; Takacs SM; Bradshaw HB; Hohmann AG
Pharmacol Res; 2013 Jan; 67(1):94-109. PubMed ID: 23127915
[TBL] [Abstract][Full Text] [Related]
7. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
9. Novel antitussive effect of suplatast tosilate in guinea pigs.
Zhou JR; Syono R; Fukumi S; Kimoto K; Shirasaki T; Soeda F; Takahama K
Pharmacology; 2015; 95(1-2):36-41. PubMed ID: 25592147
[TBL] [Abstract][Full Text] [Related]
10. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
Di Marzo V; Melck D; Orlando P; Bisogno T; Zagoory O; Bifulco M; Vogel Z; De Petrocellis L
Biochem J; 2001 Aug; 358(Pt 1):249-55. PubMed ID: 11485574
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory activity of the novel CB2 receptor agonist, GW833972A, on guinea-pig and human sensory nerve function in the airways.
Belvisi MG; Patel HJ; Freund-Michel V; Hele DJ; Crispino N; Birrell MA
Br J Pharmacol; 2008 Oct; 155(4):547-57. PubMed ID: 18695648
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system.
Cravatt BF; Lichtman AH
Curr Opin Chem Biol; 2003 Aug; 7(4):469-75. PubMed ID: 12941421
[TBL] [Abstract][Full Text] [Related]
13. Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain.
Kinsey SG; Long JZ; O'Neal ST; Abdullah RA; Poklis JL; Boger DL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Sep; 330(3):902-10. PubMed ID: 19502530
[TBL] [Abstract][Full Text] [Related]
14. Evidence for both inverse agonism at the cannabinoid CB1 receptor and the lack of an endogenous cannabinoid tone in the rat and guinea-pig isolated ileum myenteric plexus-longitudinal muscle preparation.
Makwana R; Molleman A; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):615-26. PubMed ID: 20590566
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Lichtman AH; Shelton CC; Advani T; Cravatt BF
Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
[TBL] [Abstract][Full Text] [Related]
16. TRPV1 antagonists as potential antitussive agents.
McLeod RL; Correll CC; Jia Y; Anthes JC
Lung; 2008; 186 Suppl 1():S59-65. PubMed ID: 17926096
[TBL] [Abstract][Full Text] [Related]
17. Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways.
Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
Int Arch Allergy Immunol; 2005 Sep; 138(1):80-7. PubMed ID: 16103691
[TBL] [Abstract][Full Text] [Related]
18. Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models.
Jayamanne A; Greenwood R; Mitchell VA; Aslan S; Piomelli D; Vaughan CW
Br J Pharmacol; 2006 Feb; 147(3):281-8. PubMed ID: 16331291
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 2. Discovery of 7-azaspiro[3.5]nonane urea PF-04862853, an orally efficacious inhibitor of fatty acid amide hydrolase (FAAH) for pain.
Meyers MJ; Long SA; Pelc MJ; Wang JL; Bowen SJ; Schweitzer BA; Wilcox MV; McDonald J; Smith SE; Foltin S; Rumsey J; Yang YS; Walker MC; Kamtekar S; Beidler D; Thorarensen A
Bioorg Med Chem Lett; 2011 Nov; 21(21):6545-53. PubMed ID: 21924613
[TBL] [Abstract][Full Text] [Related]
20. Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse.
Palmer JA; Higuera ES; Chang L; Chaplan SR
Neuroscience; 2008 Jul; 154(4):1554-61. PubMed ID: 18541380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
